Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops

Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops – NASDAQ News Today – EIN News

Trusted News Since 1995

A service for global professionals · Wednesday, September 4, 2019 · 495,514,385 Articles · 3+ Million Readers News Monitoring and Press Release Distribution Tools News Topics Newsletters Press Releases Events & Conferences RSS Feeds Other Services Questions?

Read More Here...

Bookmark the permalink.

Comments are closed.